RecallHawk

PLENVU (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE)

SALIX

Summary

FDA approved PLENVU (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE) by SALIX. NDA (New Drug) approval (Labeling) on 2023-09-08. FOR SOLUTION, ORAL.

Details

Source

Drug Approval

External ID

NDA209381-13

Action Date

2023-09-08

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

PLENVU (generic: POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE), FOR SOLUTION, ORAL. Application: NDA209381

Company

Context & Analysis

SALIX has 3 FDA actions in our database.

Frequently Asked Questions

How often does SALIX have FDA actions?

SALIX has 3 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA209381-13" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions